Helo Corp Announces Annual 2023 Results
Helo Corp Announces Annual 2023 Results
DUBLIN, IRELAND / ACCESSWIRE / April 24, 2024 / Helo Corp. (OTC PINK:HLOC) ("Helo" or the "Company"), a data-driven wellness technology company, announces its annual 2023 results.
愛爾蘭都柏林/ACCESSWIRE /2024 年 4 月 24 日/Helo Corp. (場外粉色:HLOC) 數據驅動的健康技術公司(“Helo” 或 “公司”)公佈了其2023年年度業績。
Helo Corp Annual Results
Helo Corp 年度業績
2023 | 2022 | Change | ||||||||||
Revenue from Continuing Operations |
$ | 4,553,764 | $ | 1,221 | NM | |||||||
Revenue from Discontinued Operations |
$ | 2,899,378 | $ | 31,320,280 | NM | |||||||
Total Revenue |
$ | 7,453,142 | $ | 31,321,501 | (76)% | |||||||
Cost of Goods Sold* |
$ | 3,146,350 | $ | 7,031,066 | (55)% | |||||||
Gross Profit* |
58% | 78% | (25)% | |||||||||
SG&A* |
$ | 8,679,374 | $ | 25,266,079 | (66)% | |||||||
Operating Loss* |
$ | (4,372,582) | $ | (975,644) | 348% | |||||||
Operating Margin* |
(59)% | (3)% | NM | |||||||||
Net Income (Loss)* |
$ | 8,783,435 | $ | (463,731) | NM | |||||||
EPS - Basic* |
$ | 0.10 | $ | 0.00 | NM | |||||||
EPS - Diluted* |
$ | 0.03 | $ | 0.00 | NM |
2023 | 2022 | 改變 | ||||||||||
來自持續經營的收入 |
$ | 4,553,764 | $ | 1,221 | NM | |||||||
來自已終止業務的收入 |
$ | 2,899,378 | $ | 31,320,280 | NM | |||||||
總收入 |
$ | 7,453,142 | $ | 31,321,501 | (76%) | |||||||
售出商品的成本* |
$ | 3,146,350 | $ | 7,031,066 | (55)% | |||||||
毛利* |
58% | 78% | (25)% | |||||||||
SG&A* |
$ | 8,679,374 | $ | 25,266,079 | (66)% | |||||||
營業損失* |
$ | (4,372,582) | $ | (975,644) | 348% | |||||||
營業利潤率* |
(59)% | (3)% | NM | |||||||||
淨收益(虧損)* |
$ | 8,783,435 | $ | (463,731) | NM | |||||||
每股收益-基本* |
$ | 0.10 | $ | 0.00 | NM | |||||||
每股收益——攤薄後* |
$ | 0.03 | $ | 0.00 | NM |
* - includes results from continuing and discontinued operations
*-包括持續經營和已終止業務的業績
NM - the percentage change was not meaningful
NM -百分比變化沒有意義
"In 2023 and into 2024, we executed our restructuring initiatives to significantly reduce our cost structure, leverage our existing technology and refocus Helo on the development of our NutraMatic and Helo AIplatform," said Sean McVeigh, Chief Executive Officer. "As we are currently tight on cash, we are seeking additional capital to fund the development and launch of these exciting innovations, which we believe will position us for substantial growth."
首席執行官肖恩·麥克維表示:“在2023年和2024年,我們執行了重組計劃,以大幅降低成本結構,利用現有技術,並將Helo的重點重新放在開發我們的NutraMatic和Helo AI平台上。”“由於我們目前現金緊張,我們正在尋求額外的資金來爲這些令人興奮的創新的開發和推出提供資金,我們相信這將使我們實現實質性增長。”
"2023 revenue from continuing operations was $4.6 million and from discontinued operations was $2.9 million, bringing our annual revenue for 2023 to $7.5 million, a decrease of 76% over the prior-year period," added David Ufheil, Chief Financial Officer. "Net Income for 2023 was $8.8 million, reflecting a $15.2 million increase in the fair value of VSC Coins that were issued to Helo in 2023, subject to a 24-month lock. We ended the year with total net assets of $19.1 million, and cash and cash equivalents of $0.3 million. The overall decline in results for 2023 reflects our shift in strategy to a new platform. In April 2024, we entered into an agreement to sell our Vyvo-focused subsidiaries. Accordingly, we have classified these operations as discontinued in our annual filing."
首席財務官戴維·烏菲爾補充說:“2023年來自持續經營業務的收入爲460萬美元,來自已終止業務的收入爲290萬美元,使我們2023年的年收入達到750萬美元,比上年下降76%。”“2023年的淨收入爲880萬美元,反映了2023年向Helo發行的VSC代幣的公允價值增加了1,520萬美元,鎖定期爲24個月。年底,我們的淨資產總額爲1,910萬美元,現金及現金等價物爲30萬美元。2023年業績的總體下降反映了我們向新平台的戰略轉移。2024年4月,我們簽訂了出售以Vyvo爲重點的子公司的協議。因此,我們在年度申報中將這些業務歸類爲已終止業務。”
About Helo Corp.
Helo Corp 公司簡介
Helo Corp. (OTC:HLOC) is a data-driven wellness technology company. Helo wearables and other smart devices are built on Helo's Life Sensing Technology, which uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters. Helo is developing the NutraMaticand Helo AI platform to leverage artificial intelligence and other technologies to analyze wearer data, provide personalized nutrition and recommendations, support the adoption of healthier lifestyle choices and drive human wellness transformation.
Helo Corp. (場外交易代碼:HLOC) 是一家數據驅動的健康技術公司。你好 可穿戴設備和其他智能設備建立在 Helo 的生命傳感技術之上,它使用最先進的傳感器、增強的信號處理和算法來收集和處理特定的生物參數。Helo 正在開發 NutraMatic和Helo AI平台,利用人工智能和其他技術來分析佩戴者數據,提供個性化營養和建議,支持採用更健康的生活方式並推動人類健康轉型。
For more information please visit helocorp.com.
欲了解更多信息,請訪問 helocorp.com。
The Company's disclosure statements and financial statements are available at OTC: HLOC.
公司的披露報表和財務報表可在以下網址查閱 場外交易:HLOC。
Forward Looking Statements
前瞻性陳述
This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "believes," and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management's current expectations, assumptions, estimates and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties. Further information regarding these and other risks is included in the Company's filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
本新聞稿包含經修訂的1933年《證券法》第27A條和經修訂的1934年《證券交易法》第21E條的定義以及1995年《美國私人證券訴訟改革法》所定義的 “前瞻性陳述”。這些前瞻性陳述可以通過 “意願”、“相信” 和類似陳述等術語來識別。本新聞稿中除歷史事實陳述以外的所有陳述均爲前瞻性陳述,涉及某些風險和不確定性,可能導致實際業績與前瞻性陳述存在重大差異。這些前瞻性陳述基於管理層當前對公司和公司運營行業的預期、假設、估計和預測,但涉及許多未知的風險和不確定性。有關這些風險和其他風險的更多信息包含在公司向場外交易市場和證券交易委員會提交的文件中。除非法律要求,否則公司沒有義務更新前瞻性陳述以反映隨後發生的事件或情況或預期的變化。儘管公司認爲這些前瞻性陳述中表達的預期是合理的,但它無法向您保證此類預期是正確的,實際業績可能與預期的業績存在重大差異。我們敦促您在評估此處包含的前瞻性陳述時仔細考慮這些因素,並提醒您不要過分依賴此類前瞻性陳述,這些前瞻性陳述完全受這些警示性陳述的限制。
Investors Contact:
investors@helocorp.com
650-646-2193
投資者聯繫人:
investors@helocorp.com
650-646-2193
SOURCE: Helo Corp.
資料來源:Helo Corp.
譯文內容由第三人軟體翻譯。